![Ruth Wolfson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ruth Wolfson worked as the Senior Vice President of Quality & Regulatory Affairs at Kamada Ltd. from 2004 to 2018.
Prior to that, she was the Head of Regulatory Affairs at Interpharm Laboratories Ltd. from 1989 to 2004.
Dr. Wolfson received her undergraduate and graduate degrees from The Hebrew University of Jerusalem and her doctorate from the Weizmann Institute of Science.
Eerdere bekende functies van Ruth Wolfson
| Bedrijven | Functie | Einde |
|---|---|---|
| KAMADA LTD. | Hoofd Techniek/Wetenschap/O&O | 02-01-2018 |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Algemeen Adviseur | 01-01-2004 |
Opleiding van Ruth Wolfson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
35
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Kies MarketScreener 
